(VIANEWS) – Capital Product Partners L.P. (CPLP), Global Ship Lease (GSL), MEDIFAST (MED) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Capital Product Partners L.P. (CPLP)

89.1% sales growth and 14.49% return on equity

Capital Product Partners L.P., a shipping company, provides marine transportation services in Greece.

Capital Product Partners L.P.’s sales growth this year is anticipated to be 24.1% and 64.2% for next year.

Year-on-year quarterly revenue growth grew by 21.4%, now sitting on 156.18M for the twelve trailing months.

Volume

Today’s last reported volume for Capital Product Partners L.P. is 93651 which is 34.84% below its average volume of 143728.

Capital Product Partners L.P.’s sales growth for the next quarter is 89.1%. The company’s growth estimates for the present quarter and the next is 76.3% and 84.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.49%.

Volatility

Capital Product Partners L.P.’s last day, last week, and last month’s current intraday variation average was 2.97%, 2.53%, and 2.21%, respectively.

Capital Product Partners L.P.’s highest amplitude of average volatility was 7.19% (day), 5.00% (last week), and 4.53% (last month), respectively.

Capital Product Partners L.P.’s Stock Yearly Top and Bottom Value

Capital Product Partners L.P.’s stock is valued at $15.92 at 15:22 EST, under its 52-week high of $16.69 and way above its 52-week low of $7.27.

Capital Product Partners L.P.’s Moving Average

Capital Product Partners L.P.’s worth is way higher than its 50-day moving average of $13.71 and way above its 200-day moving average of $12.25.

2. Global Ship Lease (GSL)

66.2% sales growth and 9.52% return on equity

Global Ship Lease, Inc. owns and charters containerships of various sizes under fixed-rate charters to container shipping companies.

Global Ship Lease’s sales growth this year is anticipated to be 30.7% and 37.2% for next year.

Year-on-year quarterly revenue growth grew by 2.9%, now sitting on 284.85M for the twelve trailing months.

Volume

Today’s last reported volume for Global Ship Lease is 717643 which is 9.24% below its average volume of 790771.

Global Ship Lease’s sales growth for the next quarter is 66.2%. The company’s growth estimates for the present quarter and the next is 111.4% and 260%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.52%.

Volatility

Global Ship Lease’s last day, last week, and last month’s current intraday variation average was 4.10%, 2.56%, and 2.95%, respectively.

Global Ship Lease’s highest amplitude of average volatility was 5.06% (day), 4.84% (last week), and 5.13% (last month), respectively.

Global Ship Lease’s Stock Yearly Top and Bottom Value

Global Ship Lease’s stock is valued at $23.14 at 15:22 EST, way below its 52-week high of $26.51 and way higher than its 52-week low of $8.78.

Global Ship Lease’s Moving Average

Global Ship Lease’s worth is below its 50-day moving average of $23.51 and way above its 200-day moving average of $18.43.

3. MEDIFAST (MED)

45.8% sales growth and 96.64% return on equity

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific.

MEDIFAST’s sales growth this year is anticipated to be 63.1% and 16.1% for next year.

Year-on-year quarterly revenue growth grew by 79.2%, now sitting on 1.27B for the twelve trailing months.

Volume

Today’s last reported volume for MEDIFAST is 113035 which is 14.91% below its average volume of 132857.

MEDIFAST’s sales growth for the next quarter is 45.8%. The company’s growth estimates for the present quarter and the next is 5.8% and 45.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 96.64%.

Volatility

MEDIFAST’s last day, last week, and last month’s current intraday variation average was 0.88%, 1.60%, and 1.96%, respectively.

MEDIFAST’s highest amplitude of average volatility was 3.14% (day), 3.48% (last week), and 3.93% (last month), respectively.

MEDIFAST’s Stock Yearly Top and Bottom Value

MEDIFAST’s stock is valued at $218.29 at 15:22 EST, way below its 52-week high of $336.99 and way above its 52-week low of $183.46.

MEDIFAST’s Moving Average

MEDIFAST’s value is higher than its 50-day moving average of $207.46 and way under its 200-day moving average of $247.13.

4. AMD (AMD)

30.8% sales growth and 60.61% return on equity

Advanced Micro Devices, Inc. operates as a semiconductor company worldwide.

AMD’s sales growth this year is expected to be 60.3% and 16.9% for next year.

Year-on-year quarterly revenue growth grew by 92.9%, now sitting on 11.42B for the twelve trailing months.

Volume

Today’s last reported volume for AMD is 60330400 which is 19.92% above its average volume of 50306400.

AMD’s sales growth for the next quarter is 30.8%. The company’s growth estimates for the present quarter and the next is 63.4% and 32.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.61%.

Volatility

AMD’s last day, last week, and last month’s current intraday variation average was 0.25%, 1.69%, and 2.44%, respectively.

AMD’s highest amplitude of average volatility was 2.26% (day), 3.87% (last week), and 4.63% (last month), respectively.

AMD’s Stock Yearly Top and Bottom Value

AMD’s stock is valued at $155.02 at 15:22 EST, under its 52-week high of $155.65 and way above its 52-week low of $72.50.

AMD’s Moving Average

AMD’s worth is way above its 50-day moving average of $116.26 and way above its 200-day moving average of $98.51.

Previous days news about AMD(AMD)

  • AMD stock price: advanced micro devices tumbles into the close to start the week. According to FXStreet on Tuesday, 23 November, "Shares of AMD fell by 1.86% on Monday, and closed the first trading session of the week at $152.52. ", "Despite the one day dip on Monday, AMD is still riding high off of its recently announced partnership with Facebook (NASDAQ:FB) or as it will soon be called, Meta. "
  • Azure virtual machines based on 3rd gen AMD EPYC 7v13 processors delivered greater performance on mysql and spark machine learning workloads at a lower cost. According to Benzinga on Wednesday, 24 November, "Despite having lower Pay-as-You-Go pricing, Azure Standard_ HB120-64rs_v3 virtual machines based on 3rd Gen AMD EPYC 7V13 processors outperformed Azure Standard_E64ds_v4 virtual machines based on Intel Xeon Platinum 8272CL processors in benchmark testing.", "Looking at Pay-as-You-Go pricing of Azure VMs, we also found that selecting Standard_HB120-64rs_v3 virtual machines with AMD EPYC 7V13 processors for the VM configurations we tested could lower a company’s monthly expenditure on cloud by as much as 21 percent compared to selecting Standard_E64ds_v4 VMs with Intel Xeon Platinum 8272CL processors."
  • AMD stock price: advanced micro devices falls as bond yields knockout growth stocks again. According to FXStreet on Wednesday, 24 November, "On Tuesday shares of AMD fell by 1.70% and closed the volatile session at $149.92. ", "While AMD was once known for its graphic chipsets, the company has evolved under CEO Dr. Lisa Su into a full spectrum chip company. "

5. UNIVERSAL INSURANCE HOLDINGS (UVE)

20.4% sales growth and 10.5% return on equity

Universal Insurance Holdings, Inc., together with its subsidiaries, operates as an integrated insurance holding company in the United States.

UNIVERSAL INSURANCE HOLDINGS’s sales growth this year is expected to be 20.8% and 10.1% for next year.

Year-on-year quarterly revenue growth declined by 7.8%, now sitting on 1.1B for the twelve trailing months.

Volume

Today’s last reported volume for UNIVERSAL INSURANCE HOLDINGS is 107712 which is 16.47% below its average volume of 128960.

UNIVERSAL INSURANCE HOLDINGS’s sales growth for the next quarter is 20.4%. The company’s growth estimates for the current quarter and the next is 139.3% and negative -13.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.5%.

Volatility

UNIVERSAL INSURANCE HOLDINGS’s last day, last week, and last month’s current intraday variation average was 0.71%, 0.72%, and 1.38%, respectively.

UNIVERSAL INSURANCE HOLDINGS’s highest amplitude of average volatility was 1.74% (day), 2.32% (last week), and 2.65% (last month), respectively.

UNIVERSAL INSURANCE HOLDINGS’s Stock Yearly Top and Bottom Value

UNIVERSAL INSURANCE HOLDINGS’s stock is valued at $15.61 at 15:22 EST, below its 52-week high of $16.57 and way above its 52-week low of $12.62.

UNIVERSAL INSURANCE HOLDINGS’s Moving Average

UNIVERSAL INSURANCE HOLDINGS’s value is way higher than its 50-day moving average of $13.97 and way higher than its 200-day moving average of $14.12.

LEAVE A REPLY

Please enter your comment!
Please enter your name here